Metronidazole description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Metronidazole

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Rx only


BOXED WARNING

PRECAUTIONS). Unnecessary use of the drug should be avoided. Its use should be reserved for the conditions described in theINDICATIONS AND USAGEsection below.

METRONIDAZOLE DESCRIPTION


Metronidazole



CLINICAL PHARMACOLOGY









Microbiology















Susceptibility Tests





INDICATIONS & USAGE

Symptomatic Trichomoniasis


Asymptomatic Trichomoniasis


Treatment of Asymptomatic Consorts


Amebiasis


Anaerobic Bacterial Infections











METRONIDAZOLE CONTRAINDICATIONS


WARNINGS).

WARNINGS

Central and Peripheral Nervous System Effects

PRECAUTIONS

General



INFORMATION FOR PATIENTS

Drug Interactions).

LABORATORY TESTS


DRUG INTERACTIONS






DRUG & OR LABORATORY TEST INTERACTIONS

Metronidazole

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY







PREGNANCY






NURSING MOTHERS


GERIATRIC USE


PEDIATRIC USE


METRONIDAZOLE ADVERSE REACTIONS












OVERDOSAGE



Treatment


DOSAGE & ADMINISTRATION



Trichomoniasis










CONTRAINDICATIONS). In pregnant patients in whom alternative treatment has been inadequate, the one-day course of therapy should not be used, as it results in higher serum levels which can reach the fetal circulation (seePRECAUTIONS, Pregnancy).





Amebiasis












Anaerobic Bacterial Infections





HOW SUPPLIED




STORAGE AND HANDLING


PROTECT FROM LIGHT


REFERENCES



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Metronidazole



Metronidazole

Metronidazole

METRONIDAZOLE TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:24236-572(NDC:50111-334)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
METRONIDAZOLE METRONIDAZOLE 500 mg

Inactive Ingredients

Ingredient Name Strength
cellulose, microcrystalline
CROSPOVIDONE
SILICON DIOXIDE
HYDROGENATED COTTONSEED OIL

Product Characteristics

Color Size Imprint Code Shape
white 16 mm PLIVA;334 OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:24236-572-04 14 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA070033 2012-08-22


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.